Unit No:  [**Numeric Identifier 68614**] Admission Date: [**2136-8-10**] Discharge Date: [**2136-8-20**] Date of Birth:  [**2136-8-10**] Sex:  M Service:  NB   HISTORY:  [**Known lastname 518**] [**Known lastname **], twin #1, was born at 35-1/7- weeks gestation by cesarean section for discordant growth and decreased growth of twin #2.
Her pregnancy was complicated by gestational hypertension and discordant growth, this twin being larger.
His last episode of bradycardia occurred on [**2136-8-18**] with a heart rate to 74 during an oral feeding.
Enteral feeds were begun on the day of delivery.
He is eating on an ad-lib schedule 24 calorie per ounce NeoSure.
Gastrointestinal status: He was begun on phototherapy on day of life #4 for a bilirubin of total 9, direct 0.3.
He was not treated with phototherapy.
Hematology: He has received any blood product transfusions during his NICU stay.
Infectious disease status: He has received no antibiotic therapy during his NICU stay.
Ferrous sulfate (25 mg per mL) 0.2 mL p.o.
PO daily to     provide 2 mg per kilograms per day of supplemental iron.
Infant multivitamins 1 mL p.o.
IMMUNIZATIONS:  Infant has received no immunizations to date.
Synagis RSV prophylaxis should be considered from     [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the     following 3 criteria: 1) born at less than 32 weeks; 2)     born between 32-35 weeks with 2 of the following: Daycare     during the RSV season, a smoker in the household,     neuromuscular disease, airway abnormalities, or school-     age siblings, or 3) with chronic lung disease.
Influenza immunization is recommended annually in the     fall for all infants once they reach 6 months of age.
Before this age and for the 1st 24 months of the child's     life, immunization against influenza is recommended for     household contacts and out-of-home caregivers.
[**Known lastname 518**] will also need SBE prophylaxis due to his VSD.
Status post prematurity at 35-weeks gestation.
